Arctic Bioscience Logo

Arctic Bioscience

Develops pharmaceutical and nutraceutical products from marine membrane lipids.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA

Description

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 476.7 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
Norwegian 476.7 KB
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 363.8 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
Norwegian 363.8 KB
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 2.3 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
English 2.4 KB
2025-11-11 12:04
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling - Attachment:…
Norwegian 346.3 KB
2025-11-11 12:04
Arctic Bioscience - Minutes of the Extraordinary General Meeting - Attachment: …
Norwegian 346.3 KB
2025-11-11 12:04
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling
Norwegian 1.6 KB
2025-11-11 12:04
Arctic Bioscience - Minutes of the Extraordinary General Meeting
English 1.6 KB
2025-11-10 07:00
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 4.1 MB
2025-11-10 07:00
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
English 4.1 MB
2025-11-10 07:00
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 9.8 KB
2025-11-10 07:00
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
Norwegian 10.0 KB
2025-11-07 08:00
Arctic Bioscience - Invitation to presentation of Q3 operational update and HeR…
English 2.1 KB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arctic Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.